Julia Simard
Publication Details
-
Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study.
Arthritis Rheum. 2010; (12): 3776-82
Reports of therapy-related adverse events suggest an elevated rate of malignancy in patients with juvenile idiopathic arthritis (JIA) treated with biologic therapies. However, the scarcity of data on the underlying risk of malignancy in JIA hampers interpretation of these signals. Therefore, the aim of this study was to determine the risk of cancer in patients with JIA as compared with that in the general population.
Help